These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6236949)

  • 1. [Treatment of hyperaldosteronism].
    Jacobelli A
    Clin Ter; 1984 Jun; 109(6):575-81. PubMed ID: 6236949
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].
    Denis B; Dimitriou R; Machecourt J; Wolf JE; Page E; Reboud JP
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():35-40. PubMed ID: 6428361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Tartagni F; Pasetti L; Ambrosioni E; Magnani B
    G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F; Remonda G; Morachioli N; Pugnani M
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):61-70. PubMed ID: 7185311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F; Wimmer M; Parth K
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F; Ambrosioni E
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
    Kuntz E
    MMW Munch Med Wochenschr; 1982 May; 124(19):465-7. PubMed ID: 6810108
    [No Abstract]   [Full Text] [Related]  

  • 11. Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism.
    Abshagen U; Spörl S; Schöneshöfer M; L'age M; Oelkers W
    Klin Wochenschr; 1978 Apr; 56(7):341-9. PubMed ID: 642407
    [No Abstract]   [Full Text] [Related]  

  • 12. Spironolactone and canrenoate: different antialdosteronic diuretic agents.
    Gentilini P
    Hepatology; 1991 May; 13(5):999-1000. PubMed ID: 2030004
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
    Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
    ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of a new water-soluble aldosterone-antagonist in surgery. Early clinical results].
    Nahum M; Ratto GB; Motta G
    Minerva Med; 1976 Apr; 67(19):1263-75. PubMed ID: 934482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of verospirone and spironolactone.
    Gãbor G; Bekes M; Polãk G; Rausch J; Gulyãs A
    Ther Hung; 1972; 20(1):36-45. PubMed ID: 5076528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypokalemic ileus and aldosteronism].
    Moeller J; Muniz B
    Med Klin; 1967 Dec; 62(52):2019-24. PubMed ID: 5596496
    [No Abstract]   [Full Text] [Related]  

  • 17. [1st results of the use of Soludactone in the treatment of certain forms of cerebral edema].
    Ravon R; Imbert D; Guibert B; Fischer G; Mansuy L
    J Med Lyon; 1970 Apr; 51(184):885-92. PubMed ID: 5476420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aldosteronism in liver diseases].
    Wildhirt E
    Z Allgemeinmed; 1974 Apr; 50(12):580-2. PubMed ID: 4839018
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spironolactone bodies. Light and electron microscope study apropos of 4 cases of adrenal adenomas with primary hyperaldosteronism].
    Vacher-Lavenu MC; Lellouch-Tubiana A; Louvel A; Daudet-Monsac M; Abelanet R
    Ann Pathol; 1982; 2(4):311-9. PubMed ID: 6297519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of diuretics in preventing ascites recurrence.
    Arrigoni A; Andriulli A; Gindro T; Verme G
    Br J Clin Pract; 1988 Mar; 42(3):116-20. PubMed ID: 3207572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.